vs

Side-by-side financial comparison of Colgate-Palmolive (CL) and Vistra Corp. (VST). Click either name above to swap in a different company.

Colgate-Palmolive is the larger business by last-quarter revenue ($5.2B vs $4.8B, roughly 1.1× Vistra Corp.). Vistra Corp. runs the higher net margin — 4.8% vs -0.7%, a 5.5% gap on every dollar of revenue. On growth, Vistra Corp. posted the faster year-over-year revenue change (31.2% vs 5.8%). Colgate-Palmolive produced more free cash flow last quarter ($1.3B vs $596.0M). Over the past eight quarters, Vistra Corp.'s revenue compounded faster (23.3% CAGR vs 1.6%).

The Colgate-Palmolive Company, commonly known as Colgate-Palmolive, is an American multinational consumer products company headquartered on Park Avenue in Midtown Manhattan, New York City. The company specializes in the production, distribution, and provision of household, health care, personal care, and veterinary products.

Vistra may refer to either of two companies:Vistra, a corporate services company based in Hong Kong Vistra Corp, an energy company based in Texas

CL vs VST — Head-to-Head

Bigger by revenue
CL
CL
1.1× larger
CL
$5.2B
$4.8B
VST
Growing faster (revenue YoY)
VST
VST
+25.4% gap
VST
31.2%
5.8%
CL
Higher net margin
VST
VST
5.5% more per $
VST
4.8%
-0.7%
CL
More free cash flow
CL
CL
$680.0M more FCF
CL
$1.3B
$596.0M
VST
Faster 2-yr revenue CAGR
VST
VST
Annualised
VST
23.3%
1.6%
CL

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CL
CL
VST
VST
Revenue
$5.2B
$4.8B
Net Profit
$-36.0M
$233.0M
Gross Margin
60.2%
Operating Margin
1.7%
9.9%
Net Margin
-0.7%
4.8%
Revenue YoY
5.8%
31.2%
Net Profit YoY
-104.9%
-47.2%
EPS (diluted)
$-0.04
$0.55

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CL
CL
VST
VST
Q4 25
$5.2B
$4.8B
Q3 25
$5.1B
$4.8B
Q2 25
$5.1B
$3.8B
Q1 25
$4.9B
$4.3B
Q4 24
$4.9B
$3.7B
Q3 24
$5.0B
$4.3B
Q2 24
$5.1B
$3.6B
Q1 24
$5.1B
$3.2B
Net Profit
CL
CL
VST
VST
Q4 25
$-36.0M
$233.0M
Q3 25
$735.0M
$652.0M
Q2 25
$743.0M
$327.0M
Q1 25
$690.0M
$-268.0M
Q4 24
$738.0M
$441.0M
Q3 24
$737.0M
$1.9B
Q2 24
$731.0M
$365.0M
Q1 24
$683.0M
$-35.0M
Gross Margin
CL
CL
VST
VST
Q4 25
60.2%
Q3 25
59.4%
Q2 25
60.1%
Q1 25
60.8%
Q4 24
60.3%
Q3 24
61.1%
Q2 24
60.6%
Q1 24
60.0%
Operating Margin
CL
CL
VST
VST
Q4 25
1.7%
9.9%
Q3 25
20.6%
21.7%
Q2 25
21.1%
13.7%
Q1 25
21.9%
-2.8%
Q4 24
21.5%
16.4%
Q3 24
21.2%
59.6%
Q2 24
21.6%
22.5%
Q1 24
20.7%
2.7%
Net Margin
CL
CL
VST
VST
Q4 25
-0.7%
4.8%
Q3 25
14.3%
13.6%
Q2 25
14.5%
8.7%
Q1 25
14.1%
-6.3%
Q4 24
14.9%
12.0%
Q3 24
14.6%
43.5%
Q2 24
14.5%
10.1%
Q1 24
13.5%
-1.1%
EPS (diluted)
CL
CL
VST
VST
Q4 25
$-0.04
$0.55
Q3 25
$0.91
$1.75
Q2 25
$0.91
$0.81
Q1 25
$0.85
$-0.93
Q4 24
$0.89
$1.09
Q3 24
$0.90
$5.25
Q2 24
$0.89
$0.90
Q1 24
$0.83
$-0.24

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CL
CL
VST
VST
Cash + ST InvestmentsLiquidity on hand
$1.4B
$785.0M
Total DebtLower is stronger
$7.8B
$15.8B
Stockholders' EquityBook value
$54.0M
$5.1B
Total Assets
$16.3B
$41.5B
Debt / EquityLower = less leverage
145.17×
3.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CL
CL
VST
VST
Q4 25
$1.4B
$785.0M
Q3 25
$1.3B
$602.0M
Q2 25
$1.2B
$458.0M
Q1 25
$1.1B
$561.0M
Q4 24
$1.3B
$1.2B
Q3 24
$1.2B
$905.0M
Q2 24
$1.1B
$1.6B
Q1 24
$1.1B
$1.1B
Total Debt
CL
CL
VST
VST
Q4 25
$7.8B
$15.8B
Q3 25
$15.8B
Q2 25
$15.5B
Q1 25
$15.4B
Q4 24
$7.0B
$15.4B
Q3 24
$13.9B
Q2 24
$13.9B
Q1 24
$14.7B
Stockholders' Equity
CL
CL
VST
VST
Q4 25
$54.0M
$5.1B
Q3 25
$856.0M
$5.2B
Q2 25
$702.0M
$4.8B
Q1 25
$363.0M
$4.8B
Q4 24
$212.0M
$5.6B
Q3 24
$435.0M
$5.4B
Q2 24
$123.0M
$5.6B
Q1 24
$230.0M
$5.7B
Total Assets
CL
CL
VST
VST
Q4 25
$16.3B
$41.5B
Q3 25
$17.5B
$38.0B
Q2 25
$17.5B
$38.1B
Q1 25
$16.6B
$38.2B
Q4 24
$16.0B
$37.8B
Q3 24
$16.8B
$37.9B
Q2 24
$16.5B
$39.1B
Q1 24
$16.6B
$38.2B
Debt / Equity
CL
CL
VST
VST
Q4 25
145.17×
3.11×
Q3 25
3.02×
Q2 25
3.22×
Q1 25
3.20×
Q4 24
33.04×
2.77×
Q3 24
2.56×
Q2 24
2.49×
Q1 24
2.60×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CL
CL
VST
VST
Operating Cash FlowLast quarter
$1.5B
$1.4B
Free Cash FlowOCF − Capex
$1.3B
$596.0M
FCF MarginFCF / Revenue
24.4%
12.4%
Capex IntensityCapex / Revenue
3.4%
17.4%
Cash ConversionOCF / Net Profit
6.15×
TTM Free Cash FlowTrailing 4 quarters
$3.6B
$1.3B

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CL
CL
VST
VST
Q4 25
$1.5B
$1.4B
Q3 25
$1.3B
$1.5B
Q2 25
$884.0M
$572.0M
Q1 25
$600.0M
$599.0M
Q4 24
$1.3B
$1.4B
Q3 24
$1.2B
$1.7B
Q2 24
$990.0M
$1.2B
Q1 24
$681.0M
$312.0M
Free Cash Flow
CL
CL
VST
VST
Q4 25
$1.3B
$596.0M
Q3 25
$1.1B
$1.0B
Q2 25
$776.0M
$-118.0M
Q1 25
$476.0M
$-169.0M
Q4 24
$1.1B
$923.0M
Q3 24
$1.0B
$1.0B
Q2 24
$873.0M
$698.0M
Q1 24
$555.0M
$-153.0M
FCF Margin
CL
CL
VST
VST
Q4 25
24.4%
12.4%
Q3 25
21.6%
21.1%
Q2 25
15.2%
-3.1%
Q1 25
9.7%
-4.0%
Q4 24
21.9%
25.2%
Q3 24
20.5%
23.4%
Q2 24
17.3%
19.4%
Q1 24
11.0%
-4.8%
Capex Intensity
CL
CL
VST
VST
Q4 25
3.4%
17.4%
Q3 25
3.0%
9.6%
Q2 25
2.1%
18.4%
Q1 25
2.5%
18.1%
Q4 24
3.7%
11.7%
Q3 24
2.7%
15.8%
Q2 24
2.3%
13.8%
Q1 24
2.5%
14.7%
Cash Conversion
CL
CL
VST
VST
Q4 25
6.15×
Q3 25
1.72×
2.25×
Q2 25
1.19×
1.75×
Q1 25
0.87×
Q4 24
1.72×
3.07×
Q3 24
1.58×
0.90×
Q2 24
1.35×
3.28×
Q1 24
1.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CL
CL

Other$3.0B58%
Pet Nutrition$1.2B23%
Oral Personal And Home Care$1.0B20%

VST
VST

Retail Energy Charge In ERCOT$2.1B43%
Retail Energy Charge In Northeast Midwest$1.2B24%
East Segment$1.1B24%
Hedging Revenue Realized$170.0M4%
Revenue From Other Wholesale Contracts$116.0M2%
Transferable Production Tax Credit Revenues$78.0M2%
West Segment$77.0M2%
Intersegment Sales$25.0M1%

Related Comparisons